StockData
International Stem Cell CORP logo

International Stem Cell CORP (ISCO) stock

ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.28+0.00 (+0.89%)

Close on Oct 19, 2026Market cap $2.27MP/E –Yield –

International Stem Cell enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

International Stem Cell's enterprise value was $1.18M on Oct 19, 2026, against $280.66K a year earlier. Over the last 5 years it ranged from -$949.74K to $3.67M, with a median of $234.66K.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$1.18M+660.8%
2025Dec 31, 2025$154.61K–
2024Dec 31, 2024-$656.24K–
2023Dec 29, 2023-$949.74K-222.6%
2022Dec 30, 2022$774.79K-74.3%
2021Dec 31, 2021$3.01M+70.8%
2020Dec 31, 2020$1.76M-54.9%
2019Dec 31, 2019$3.91M-56.3%
2018Dec 31, 2018$8.94M+47.4%
2017Dec 29, 2017$6.06M+102.5%
2016Dec 30, 2016$2.99M-53.9%
2015Dec 31, 2015$6.49M-57.4%
2014Dec 31, 2014$15.23M-42.3%
2013Dec 31, 2013$26.38M+93.6%
2012Dec 31, 2012$13.63M-53.2%
2011Dec 30, 2011$29.14M–

More International Stem Cell figures

See a number that looks wrong?